1. Platelet-activating factor and inflammatory bowel disease;F, Stenson W.;Gastroenterology,1988
2. Leukocyte dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor;Benveniste, J.; M, Henson P.; G, Cochrane C.;J Exp Med,1972
3. Semi-synthese et structure proposee du facteur activant les plaquettes (P. A. F.): paf-acether, un alkyl4ther analogue de la lysophosphatidylcholine;Benveniste, J.; Tence, M.; Varenne, P.; Bidault, J.; Boullet, C.; Polonsky, J.;Compte Rendu of the Academy ofSciences (Paris) Serie D,1979
4. Plateletactivating factor. Evidence for 1-O-alkyl-2-acetyl-snglyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators);A, Demopoulos C.; N, Pinckard R.; J, Hanahan D.;J Biol Chem,1979
5. Aggregation of human platelets by platelet-activating factor;Benveniste, J.; P, Le Couedic J.; Kamoun, P.;Lancet,1975